ETF Managers Group, LLC Immunome Inc. Transaction History

ETF Managers Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.24 - $5.79 $8,220 - $21,249	-3,670 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.88 - $13.99 $46 - $167	12 Added 0.33%	3,670 $20,000
Q4 2021 Feb 14, 2022	SELL	$12.96 - $23.44 $7,024 - $12,704	-542 Reduced 12.9%	3,658 $51,000
Q3 2021 Nov 15, 2021	BUY	$12.5 - $27.76 $9,112 - $20,237	729 Added 21.0%	4,200 $101,000
Q2 2021 Aug 16, 2021	BUY	$16.33 - $32.33 $3,608 - $7,144	221 Added 6.8%	3,471 $61,000
Q1 2021 May 17, 2021	BUY	$9.56 - $43.24 $31,070 - $140,530	3,250 New	3,250 $100,000

121

47.1M

322K

1.91M

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $127M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.